Coherus Oncology Inc (CHRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 83,034 | 110,419 | 113,551 | 135,674 | 116,180 |
| Cost of Goods | 7,511 | 11,673 | 9,000 | 10,139 | 6,855 |
| Gross Profit | 75,523 | 98,746 | 104,551 | 125,535 | 109,325 |
| Operating Expenses | 243,394 | 82,994 | 70,835 | 60,364 | 69,312 |
| Operating Income | -167,360 | 16,425 | 33,716 | 65,310 | 40,868 |
| Interest Expense | 5,648 | 5,671 | 5,656 | 5,408 | 4,431 |
| Other Income | 61 | 7 | 56 | 423 | 68 |
| Pre-tax Income | -172,947 | 10,761 | 28,116 | 60,325 | 36,505 |
| Income Tax | N/A | 1,053 | 183 | 1,294 | 933 |
| Net Income Continuous | -172,947 | 9,708 | 27,933 | 59,031 | 35,572 |
| Net Income | $-172,947 | $9,708 | $27,933 | $59,031 | $35,572 |
| EPS Basic Total Ops | -2.37 | 0.13 | 0.39 | 0.83 | 0.50 |
| EPS Basic Continuous Ops | -2.37 | 0.13 | 0.39 | 0.83 | 0.50 |
| EPS Diluted Total Ops | -2.37 | 0.11 | 0.33 | 0.70 | 0.48 |
| EPS Diluted Continuous Ops | -2.37 | 0.12 | 0.32 | 0.67 | 0.48 |
| EBITDA(a) | $-166,511 | $17,265 | $34,409 | $66,058 | $41,475 |